• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Key Features of Some of the Latest Monofocal Aspheric IOLs

Opinion
Video

Seth Pantanelli, MD discusses the landscape of monofocal aspheric intraocular lenses (IOLs) and how he caters treatment options to each patient.

Summary

Seth Pantanelli, MD discusses several monofocal intraocular lenses (IOLs) he favors in his practice, emphasizing their unique features and advantages. He mentions the enVista, a neutral aspheric lens known for being glistening-free and versatile in a wide power range. Pantanelli values the stability of the enVista, especially in cases of de-centered or irregular astigmatism. Another lens he highlights is the CT Lucia 621, which features a distinctive aspheric profile with negative spherical aberration in the center, transitioning to neutral and then positive in the periphery. This design aims to optimize vision quality in various lighting conditions and lens positions. The CT Lucia 621 also stands out for its exceptional clarity inside the eye and absence of glistening.

Pantanelli emphasizes that the choice of monofocal IOL depends on various factors, such as the patient's corneal condition, refractive history, and personal preferences. For patients with irregular astigmatism, he leans towards neutral aspheric lenses, while those with a history of hyperopic LASIK may benefit from older spherical IOLs with negative spherical aberration.

Related Videos
William F. Wiley, MD, shares some key takeaways from his ASCRS presentation on binocularity and aperture optics.
© 2024 MJH Life Sciences

All rights reserved.